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a  b  s  t  r  a  c  t
Aim: The main purpose of this study is to perform a dosimetric comparison on target vol-
umes and organs at risks (OARs) between prostate intensity modulated treatment plans
(IMRT) optimized with different multileaf collimators (MLCs).
Background: The use of MLCs with a small leaf width in the IMRT optimization may improve
conformity around the tumor target whilst reducing the dose to normal tissues.
Materials and methods: Two linacs mounting MLCs with 5 and 10 mm leaf-width, respectively,
implemented in Pinnacle3 treatment planning system were used for this work. Nineteen
patients with prostate carcinoma undergoing a radiotherapy treatment were enrolled. Treat-
ment planning with different setup arrangements (7 and 5 beams) were performed for each
patient and each machine. Dose volume histograms (DVHs) cut-off points were used in the
treatment planning comparison.
Results: Comparable planning target volume (PTV) coverage was obtained with 7- and 5-
beam configuration (both with 5 and 10 mm MLC leaf-width). The comparison of bladder
and  rectum DVH cut-off points for the 5-beam arrangement shows that 52.6% of the plans
optimized with a larger leaf-width did not satisfy at least one of the OARs’ constraints. This
percentage is reduced to 10.5% for the smaller leaf-width. If a 7-beam arrangement is used
the  value of 52.6% decreases to 21.1% while the value of 10.5% remains unchanged.Conclusion: MLCs collimators with different widths and number of leaves lead to a compa-
rable  prostate treatment planning if a proper adjustment is made of the number of gantry
angles.
©  2015 Greater Poland Cancer Centre. Published by Elsevier Sp. z o.o. All rights reserved.∗ Corresponding author. Tel.: +39 3201567683.
E-mail address: cplfulcheri@gmail.com (C. Fulcheri).
http://dx.doi.org/10.1016/j.rpor.2015.06.005
1507-1367/© 2015 Greater Poland Cancer Centre. Published by Elsevier Sp. z o.o. All rights reserved.




















































Table 1 – Physical properties of the 160 MLCTM and the
OPTIFOCUS 82MLCTM mounted respectively on Artiste
and Oncor linacs.
160 MLCTM 82 MLCTM
Number of leaves 160 82
Leaves design Single focused Double focused
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.  Background
ntensity modulated radiation therapy (IMRT) is an advanced
orm of external beam radiation therapy involving the deliv-
ry of multiple beams at different angles around the patient.
his technique has the ability to improve dose distributions
n a way that results in a higher conformity around the tumor
arget whilst reducing the dose to normal tissues. The clin-
cal evidence for the effectiveness of IMRT is encouraging.1
MRT  treatment delivery requires the use of multileaf colli-
ators (MLC). Over the years, linear accelerator vendors have
ot only improved the reliability of MLCs but also made the
eaf-width smaller. Smaller leaf-width allows the treatment
lanning system to use a finer beamlet size during optimiza-
ion achieving a better plan quality.
The IMRT  planning process involves two steps: the first one
onsists in an idealized pencil beam dose calculation and dose
ptimization; the other one in the final dose calculation based
n the actual physical beam apertures. Consequently there
re differences between the pencil beam calculation and opti-
ization and the corresponding dose distribution that takes
nto account collimator-specific effects. The purpose of this
ork was a dosimetric comparison of prostate IMRT plans
ptimized for two  linacs having different multileaf collima-
ors. The plan optimization was carried out using the same
arameters. The treatment delivery accuracy of the different
lans was validated by performing patient specific intensity
odulated radiation therapy quality assurance (IMRT QA)
sing a two dimensional (2D) ion chamber array.2
.  Materials  and  methods
.1.  Machines  characterization
n our department, Siemens Medical Solutions (Erlangen,
ermany) machines are available, namely an ArtisteTM and an
ncorTM Impression linear accelerator, mounting respectively
 160 and a 82 OPTIFOCUS MLCs. The dosimetric characteris-
ics of both MLCs have been previously described.3,4
The 160 MLCTM has 160 leaves (80 on each side) with a leaf-
idth of 5 mm over the full field of 400 mm × 400 mm.  The
ivergent jaws allow an automatic focus to the field edge (sin-
le focused); the leaves are mounted in the two leaf banks,
ach in a moveable carriage that allows the leaves to extend
orizontally 200 mm from the carriage so that, in combination
ith the carriage movement, a displacement across the entire
eld from −200 to +200 mm is possible. To reduce the inter-
eaf leakage, the leaf ends are shaped with curved upper and
ower portions and with a sinusoidal central portion allowing
 slight overlap of both sides. As tongue- and groove system,
he leaves are slightly tilted in order to avoid a straight open
ir gap for central rays of the beam. Upper leaves are shifted
lightly upwards to lead to a different length of the overlap
egion between two  neighboring leaves.The OPTIFOCUSTM MLC  collimator is equipped with 82
eaves of projected width of 10 mm for the entire field. A
ouble-focus leaf design follows the beam divergence so that
he end and side of the leaves follow the beam divergenceLeaf movement gap
(mm)
400 300
in both directions. The movement  of the leaves across the
entire field is from −100 to 100 mm.  The physical properties
of the two different collimators are summarized in Table 1;
some accelerator beam data measured according to the IAEA
code of practice,5 used for the linacs commissioning and for
the implementation of the treatment planning system, were
reported in Table 2. In Fig. 1 the percentage depth doses and
the profiles for the reference field were reported for the 5-mm
and 10-mm MLC linac, respectively.
2.2.  Clinical  cases
Nineteen patients with prostate carcinoma undergoing either
a radical or an adjuvant postoperative prostate treatment,
routinely treated with IMRT, were selected for this study. All
patients were treated according to our protocols and received a
prescribed dose of 80 Gy and 70 Gy, respectively, for radical and
adjuvant treatment, in 2 Gy daily fractions. The CTV included
the prostate and vesicles or the prostatic lodge for the radi-
cal or adjuvant treatment, respectively. The PTV was obtained
by adding 5 mm margin to the CTV, except 4 mm  posteriorly
to limit the rectal dose. If lymph nodes were included in the
CTV, the same margin was adopted. Patients were instructed
to maintain an empty rectum and a full bladder for the plan-
ning CT and for the treatment. All patients were treated with
6 MV photons and underwent a daily IGRT using a megavolt-
age cone-beam CT (MV-CBCT). The daily CBCT doses were
included in the DVHs presented in this study and approved
by the radiation oncologist.
2.3.  Treatment  techniques  and  planning  optimization
For each clinical case, a Step & Shoot IMRT  treatment plan
was performed both with the Artiste and with the Oncor
model, using identical procedures and beam setup arrange-
ment. Pinnacle3 treatment planning system (P3IMRT,  Version
9.0, Philips Medical Division, Madison, WI)  using the direct
machine parameters optimization (DMPO) approach was used
for this purpose. For each plan, both 5- and 7-beam configura-
tion was studied. Equally spaced gantry angles were set for the
7-beam configuration, while 180◦, 250◦, 315◦, 100◦, 45◦ gantry
angles were used for the 5-beam configuration. No distinction
on gantry angles was used for radical or adjuvant treatments.
The number of segments was set to 10 per beam for every plan
and the minimum number of monitor units (MUs) for segment
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Table 2 – Tissue Phantom Ratio (TPR2010), depth of maximum dose (Dmax), absolute output (cGy/MU) for a reference field
for Siemens Artiste and Oncor linacs.
ARTISTE ONCOR
6 MV 18 MV 6 MV 18 MV
TPR2010 0.674 0.775 0.674 0.771
Dmax (cm) 1.51 3.01 1.50 3.00
Absolute calibration
(cGy/MU), SSD 100,
d = 10 cm, 10 cm × 10 cm
0.666 0.761 0.667 0.759
Fig. 1 – The percentage depth doses (PDDs) and the profiles for the reference field were  reported for the 5-mm and 10-mm
MLC’s linac.
Table 3 – Prostate IMRT  protocol with dose-volume
constraints used for IMRT  planning. All constraints are
based on a 2 Gy/fraction.







Femoral heads 30 50
Femoral heads 50 35
and Dmax cut-off points were used for the PTV dose cover-Small bowel 15 120cc
Small bowel 45 195cc
equal to 2 (according to our quality assurance protocol, the
dose linearity is better than 0.5% for 2 MUs  delivered); the dose
grid resolution was set to 0.2 cm × 0.2 cm × 0.2 cm and the cone
convolution algorithm was used for the dose calculation. The
100% of the dose was prescribed to the mean PTV volume.
The plan optimization was based on dose volume objectives
for planning target volumes (PTVs) and on the OAR constraints
commonly adopted in clinical practice6,7 (Table 3). We strived
to reach a final plan delivering 100% of the prescription dose
to at least 95% of the tumor volume, no more  than 105% of the
prescription dose to no more  than 1% of the tumor volume,
while ensuring OAR dose as low as achievable. Optimization
was considered completed when PTV was adequately covered
with the prescription dose, when the optimization reached
a plateau in the cost function and when it was determined
(increasing the weight or setting a lower OAR constraint inthe optimization) that no further gain could be achieved in
sparing OARs without compromising target coverage. To avoid
operator-dependent errors, the plan optimization was carried
out always by the same experienced medical physicist. Every
plan was first optimized with Artiste MLC and, secondly, with
the Oncor MLC model maintaining exactly the same configura-
tion and optimization parameters. For plan QA verification the
dose distribution of each IMRT  plan was recalculated on the
CT scan of an IBA MatriXX Evolution phantom8–9 sandwiched
between 5.5 and 7.0 cm of a 30 cm × 30 cm × 1 cm phantom
slabs at a zero gantry angle. Measured and calculated planar
dose distributions were compared using gamma evaluation
with 3 mm distance-to-agreement and 3% dose difference end
points.10–12
2.4.  Criteria  for  treatment  plan  evaluation  and
comparison
To compare the treatment plans derived from the two dif-
ferent optimizations, DVH cut-off points and maximum dose
received Dmax, global conformity index (GCI) were used for tar-
get evaluation, while only DVH cut-off points were used for the
OAR sparing comparison. We defined the DVH cut-off points
Dx (or Dx%) as the dose expressed in gray (Gy) received by x
volume in cc (or x% of the total volume). We  defined Dmax as
the dose received by 1 cm3 of the target volume. D98%, D95%age comparison; for critical structures, clinically relevant DVH
cut-off points depend on the dose delivered. For the bladder
we used D50%, D35%, D20%, while for the rectum we  used D60%,





































ig. 2 – Dose volume histogram for an exemplary patient. Th
eft) were  illustrated. The 5-mm MLC  (dotted line) and 10-mm
50%, D20%. The cut-off points for the OARs were evaluated
ndividually, but also together for the overall acceptance crite-
ia of the patient; a treatment planning will be considered to
espect the overall OAR constraints if each single cut-off point
or the rectum and bladder was respected. The GCI provides
 score expressing the relationship between irradiated tumor






here TV, TV98% represent the target volume and the target
olume covered by 98% of the prescription dose, respectively,
hile V98% the generic volume covered by 98% of the prescrip-
ion dose. The TV98% to V98% ratio is a measure of the coverage
uality; it represents the fraction of the volume of healthy tis-
ue receiving a dose greater than or equal to the prescribed
eference dose; it takes into account exclusively the irradia-
ion of healthy tissues and it measures the proportion of the
olume receiving 98% of the prescription dose that covers indi-
ectly the volume of healthy tissue. The GCI index can help to
valuate the protection of healthy tissues. The GCI ranges from
 to 1, where 1 is the ideal value. A value close to 0 indicates
ither total absence of conformation, i.e. the target volume is
ot irradiated, or a very large irradiation volume compared to
he target volume; irradiation was considered to be conformal
f and only if the GCI was greater than 0.6.
Treatment plans were compared based on the relative per-
entage differences (%diff D) at above mentioned DVH cut
oints for the PTV, bladder and rectum;
diff D = 100 ∗ Dx%5-mm − Dx%-mm
Dx%5-mm
here Dx% 5-mm is the dose expressed in Gy received by x%
f the volume when the 5-mm collimator optimization is per-
ormed. A negative percentage difference indicates for 5-mm
LC  optimization, a lower dose as compared to the ones per-
ormed with the 10-mm MLC; and vice versa, a positive value
f the percentage difference indicates a greater dose received
t this point for the 5-mm MLC  optimization.Hs for 7 (on the right) and 5 beams configuration (on the
C  (continuous line) results were  shown.
3.  Results
3.1.  PTV  coverage
The two linacs, regardless of the MLCs leaf-width, provided
plans with satisfactory target coverage both with the 5- and 7-
beam configuration. In Fig. 2, the DVH of an exemplary patient
for the 7 and 5 beam configuration was reported both with the
5-mm MLC and 10-mm MLC plan optimization. The difference
on the OAR cut-off points are less evident in the 7-beam con-
figuration. In both cases the 5 mm-MLC collimator present a
lower maximum dose. This result was expected considering
that IMRT optimization has maximum priority over the vol-
ume  to be treated. In order to highlight possible dosimetric
differences obtained by optimizing the IMRT  planning with
the 5-mm vs. 10-mm MLC, in Table 4 the PTV dose percentage
differences for D98%, D95% and Dmax were reported for both 5-
and 7-beam arrangement.
As can be observed, almost every D98% and D95% percentage
difference had a positive value (70 positive points out of 76).
This indicates that 5-mm MLC optimization leads to a better
PTV coverage than 10-mm MLC, regardless of the number of
beams used for the treatment planning. The average percent-
age target volume covered by the prescription dose is 97% and
95% for the 5-mm and 10-mm MLCs plans, respectively.
Both in the case of 5- and 7-beam arrangement, the 5-mm
MLC optimization always leads to a maximum dose lower than
in 10-mm MLC one. This is outlined by the Dmax column which
shows 100% of the values with a negative percentage differ-
ence. These percentage differences correspond to a maximum
dose difference ranging between 1 and 1.5 Gy, with a mean
value of 1.1 Gy. Those results were expected due to the dif-
ference between 10-mm and 5-mm MLCs leakage effect. The
analysis performed separately on the radical and adjuvant
treatments leads to the same results.
With regard to GCI, the mean, minimum and maximum
values obtained for the 5-mm-MLC optimization were 0.89,
0.85, 0.92 versus 0.86, 0.83, 0.89, respectively, for the 10-mm
MLC  optimization. The GCI obtained for the 5-mm MLC  width
were superior than the 10-mm MLC, while no difference
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Table 4 – Percentage difference in PTV coverage for the cut off points D98%, D95% and Dmax obtained for the 5-mm MLCs
(Artiste) vs 10-mm MLCs (Oncor) optimization in the five beams (5b) and seven beams (7b) arrangement. The percentage
difference was defined as %diff D = 100 * (Dx% 5-mm − Dx% 10-mm)/Dx% 5-mm). Cases from 1 to 9 and 10 to 19 were referred to
radical and adjuvant treatments respectively.
Case Volume (cc) D98% 5b (7b) D95% 5b (7b) Dmax 5b (7b)
1 125 1.3 (2.1) 0.7 (0.5) −0.1 (−1.3)
2 178 0.9 (0.3) 0.9 (−0.1) −0.1 (−1.1)
3 171 −0.3 (2.3) 0.8 (1.2) −0.8  (−0.6)
4 223 2.9 (0.0) −0.4  (0.3) −1.8 (−0.3)
5 229 1.4 (0.2) 0.9 (0.5) −5.2 (−0.9)
6 151 0.6 (0.7) 0.5 (0.6) 0.0 (−0.8)
7 167 0.5 (0.6) 0.1 (0.1) −1.0 (−0.5)
8 221 0.8 (1.0) 0.5 (0.7) −1.3 (−1.3)
9 208 −0.1 (−0.3) 0.0 (−0.2) −0.7 (−0.6)
10 148 1.9 (2.2) 1.3 (1.1) −0.8 (−0.3)
11 126 1.0 (0.0) 1.0 (0.1) −0.6 (−0.8)
12 147 2.5 (1.9) 0.4 (0.9) −1.3 (0.0)
13 144 0.4 (0.3) 0.0 (0.3) −2.8 (−0.4)
14 167 0.2 (0.6) 0.3 (0.2) −0.2 (−0.3)
15 204 1.0 (0.5) 0.6 (0.2) −0.3 (−0.9)
16 157 0.9 (1.1) 0.3 (1.2) −2.1 (−1.7)
17 173 0.8 (1.1) 0.3 (0.7) −2.3 (−3.4)
18 216 2.3 (2.2) 1.2 (1.5) −0.7 (−1.9)
0.3)
0.9) 
0.8) 19 170 0.2 (
Mean 175 1.0 (
Std-dev 33 0.9 (
may be outlined for configurations with different numbers
of beams. These high values obtained came from the priority
given in the optimization to PTV coverage and conformation
stressed using ring regions of interest (ROIs) around the PTV.
3.2.  OAR  dose  constraints
Table 5 shows, for each beam configuration (5 vs. 7 beams)
and MLC  optimization (10 vs. 5-mm MLC), the percentage of
patients failing the single OAR DVH cut-off point for the blad-
der and rectum adopted in our center and reported in Table 3,
and in the last column the overall failing criteria in terms of
the failure ratio. If the five-beam arrangement was combined
with the 10-mm MLC  optimization, only 47.4% (overall) of the
IMRT  planning met  the constraints; this percentage raises up
to 89.5% for the 5-mm MLC. These results suggest the need to
re-optimize the IMRT  planning. The new optimization coming
from an increase in the overall number of beam entries (from
5 to 7) resulted in an improvement of the respected cut-off
point constraints; in particular, overall percentages of failure
cases obtained in the worst case were decreased from 52.6%
to 21.1%, while the failure percentage of 10.5% for the 5-mm
MLC  remains unchanged. This can be explained by the partic-
ular conformation of the bladder and rectum, respectively, of
two of the nineteen patients of this study that made it impos-
sible to fulfill all OAR constraints to keep a good PTV coverage.
These two patients did not satisfy 2 out of 4 reference con-
straints, in particular the rectum cut-off point D60% and D50%
for one patient, and the bladder D50% and D35% cut-off points
for the other one.
If we  now focus our analysis on the values obtained for the
rectum and bladder, we can state that every plan performed
with the 7-beam configuration, independently from the MLC
characteristics, respects the single constraints of the OARs
(except for two patients as discussed above). In general the0.4 (0.4) 0.0 (0.0)
0.5 (0.5) −1.2 (−0.9)
0.4 (0.5) 1.3 (0.8)
results related to the bladder and rectum are quite similar; for
convenience, in Table 6 we reported only the details obtained
for bladder cut-off points.
It can be observed that every value, except one, in Table 6 is
less or equal to zero; this outlines that with a 5-mm MLC  opti-
mization, the doses received by the bladder at the DVH cut-off
points investigated were in general lower (113 points out of
114), independently from the beam arrangement; the same
may be observed for the rectum. The high difference obtained
for the case 19 is due to a very low dose value of the D50%
obtained: 6 Gy vs. 8 Gy for 5-mm and 10-mm MLCs optimiza-
tion, respectively. This result implies that the conclusions of a
recent work about the usage of a box 3D Conformal Radiother-
apy technique in treating prostate cancer14 may be extended
to include IMRT.
It is also important to highlight that the differences in the
treatment optimization resulting from the two different MLCs
were reduced by switching from 5- to 7-beam arrangement. In
Table 6, this difference was smoother in 49 out of 57 cut-off
points, meaning a better bladder DVH agreement. Similar are
the findings for the rectum.
In the OAR analysis, no particular distinction was observed
between radical or adjuvant treatments, nor evidence of dif-
ferent behavior connected with the OAR volumes.
3.3.  Treatment  plan  verification
As stated before, measured dose data from delivering the
treatment fluence map  on the IMRT phantom and calcu-
lated planar dose distributions were compared using gamma
evaluation with 3 mm distance-to-agreement and 3% dose
difference end points. According to gamma evaluation, the
comparison performed showed an excellent conformity. The
agreement between the two dose distribution data was
expressed by the percentage of the measured points in
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Table 5 – Percentage of patients failing the single OAR constraints for bladder and rectum. In the last column the overall
failing criteria is also reported (in bracket) in term of failure patient ratio.
Bladder Rectum OARs Overall
D50% D35% D20% D60% D50% D20%
5 Beams
10-mm MLC 5.3% 26.3% 5.3% 15.8% 10.5% 15.8% 52.6% (10/19)
5-mm MLC 5.3% 5.3% 0.0% 5.3% 5.3% 0.0% 10.5% (2/19)
7 Beams
10-mm MLC 5.3% 5.3% 0.0% 10.5% 5.3% 0.0% 21.1% (4/19)
5-mm MLC 5.3% 5.3% 0.0% 5.3% 5.3% 0.0% 10.5% (2/19)
Table 6 – Percentage difference for bladder DVHs cut off points D50%, D35%, D20%, resulting from 5-mm MLC (Artiste) vs.
10-mm MLC  (Oncor) optimization in the five beams (5b) and seven beams (7b) arrangement. The percentage difference
was defined as %diff D = 100 * (Dx% 5-mm − Dx% 10-mm)/Dx% 5-mm). Cases from 1 to 9 and 10 to 19 were  referred to radical and
adjuvant treatments respectively. Positive values are highlighted in bold.
Case 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Mean
D50%
5b −8.7 0.0 −9.1 −2.0 −7.0 −5.3 −24.0 −2.6 0.0 0.0 0.0 −11.4 0.0 0.0 0.0 −10.3 −3.6 0.0 −33.3 −6.2
7b −7.7 0.0 0.0 0.0 2.0 −2.1 0.0 −6.7 0.0 −3.4 −3.2 −7.7 0.0 −0.9 −5.3 −9.5 −5.7 0.0 −33.3 −4.4
D35%
5b 0.0 −0.7 −4.8 −5.1 −9.1 −9.6 −4.5 −2.2 0.0 −7.0 −2.2 −8.0 −2.9 −4.4 0.0 0.0 −2.9 3.4 −25.0 −4.4
7b 0.0 −0.7 −2.4 0.0 −1.6 −7.1 0.0 0.0 0.0 −6.0 0.0 −1.8 0.0 0.0 0.0 −10.7 0.0 0.0 −22.7 −2.8
D



























20% 7b −6.0 0.0 −3.5 0.0 −1.4 −2.1 0.0 0.0 0
Vol (cc) 195 58 254 118 223 104 223 207 124
ccordance with the calculated ones inside the area defined
y 20% and 90% dose level. These percentages give a gamma
istribution in the 20% dose level13 area always higher than
5%, with mean value of 96% and in the 90% dose level area
lways higher than 97% with mean value of 98.5%.
.  Conclusions
he present work outlines that the use of the two different
LC  delivery techniques considered in prostate IMRT  plan-
ing resulted both in a good PTV coverage and sparing of the
ARs. The use of 10-mm leaf-width collimator may require an
ncrease in the total number of beamlets and beam entries in
rder to fulfill OAR constraints maintaining a good PTV cov-
rage. The 7-beam arrangement allows a comparable DVH for
he two different MLC  optimizations, even if a higher maxi-
um dose persists for the 10-mm MLC. The clinical relevance
f these results should be assessed on patient base; the num-
er of patients involved in this study was too small to achieve
eliable results but enough to share the possibility to achieve
ood clinical results even with a minor technology.
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